Age-Related Maculopathy
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
PfizerRN6G
GenentechLucentis
Clinical Trials (2)
Total enrollment: 65 patients across 2 trials
Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration
Start: Apr 2009Est. completion: Jul 2011
Phase 1Completed
Study Evaluating Genotypes Using Lucentis
Start: May 2007Est. completion: Dec 200965 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space